nodes	percent_of_prediction	percent_of_DWPC	metapath
Erlotinib—ABCG2—primary biliary cirrhosis	0.362	0.696	CbGaD
Erlotinib—ALB—primary biliary cirrhosis	0.158	0.304	CbGaD
Erlotinib—CYP2C8—Colchicine—primary biliary cirrhosis	0.0433	0.347	CbGbCtD
Erlotinib—CYP3A4—Chenodeoxycholic acid—primary biliary cirrhosis	0.0348	0.278	CbGbCtD
Erlotinib—ABCB1—Colchicine—primary biliary cirrhosis	0.0293	0.235	CbGbCtD
Erlotinib—CYP3A4—Colchicine—primary biliary cirrhosis	0.0176	0.141	CbGbCtD
Erlotinib—Ulcerative keratitis—Colchicine—primary biliary cirrhosis	0.00701	0.0367	CcSEcCtD
Erlotinib—Acute respiratory distress syndrome—Colchicine—primary biliary cirrhosis	0.00678	0.0355	CcSEcCtD
Erlotinib—ORM1—bile—primary biliary cirrhosis	0.00676	0.226	CbGeAlD
Erlotinib—Pulmonary fibrosis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00362	0.0189	CcSEcCtD
Erlotinib—Pulmonary fibrosis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00362	0.0189	CcSEcCtD
Erlotinib—Lung infiltration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00339	0.0178	CcSEcCtD
Erlotinib—Lung infiltration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00339	0.0178	CcSEcCtD
Erlotinib—Interstitial pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00329	0.0172	CcSEcCtD
Erlotinib—Interstitial pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00329	0.0172	CcSEcCtD
Erlotinib—Myopathy—Colchicine—primary biliary cirrhosis	0.00252	0.0132	CcSEcCtD
Erlotinib—Peptic ulcer—Chenodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0125	CcSEcCtD
Erlotinib—Peptic ulcer—Ursodeoxycholic acid—primary biliary cirrhosis	0.00238	0.0125	CcSEcCtD
Erlotinib—Interstitial lung disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0118	CcSEcCtD
Erlotinib—Interstitial lung disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0118	CcSEcCtD
Erlotinib—Lung disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0118	CcSEcCtD
Erlotinib—Lung disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00225	0.0118	CcSEcCtD
Erlotinib—Rhabdomyolysis—Colchicine—primary biliary cirrhosis	0.002	0.0105	CcSEcCtD
Erlotinib—Acne—Chenodeoxycholic acid—primary biliary cirrhosis	0.00189	0.0099	CcSEcCtD
Erlotinib—Acne—Ursodeoxycholic acid—primary biliary cirrhosis	0.00189	0.0099	CcSEcCtD
Erlotinib—ORM1—gall bladder—primary biliary cirrhosis	0.00188	0.0628	CbGeAlD
Erlotinib—Cardiovascular disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00948	CcSEcCtD
Erlotinib—Cardiovascular disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00181	0.00948	CcSEcCtD
Erlotinib—NR1I2—liver—primary biliary cirrhosis	0.0018	0.0603	CbGeAlD
Erlotinib—Hepatocellular injury—Colchicine—primary biliary cirrhosis	0.00177	0.00927	CcSEcCtD
Erlotinib—Cellulitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00916	CcSEcCtD
Erlotinib—Cellulitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00175	0.00916	CcSEcCtD
Erlotinib—Drug interaction—Chenodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00898	CcSEcCtD
Erlotinib—Drug interaction—Ursodeoxycholic acid—primary biliary cirrhosis	0.00171	0.00898	CcSEcCtD
Erlotinib—Bone pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0087	CcSEcCtD
Erlotinib—Bone pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00166	0.0087	CcSEcCtD
Erlotinib—ALB—gall bladder—primary biliary cirrhosis	0.00165	0.0551	CbGeAlD
Erlotinib—Musculoskeletal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00843	CcSEcCtD
Erlotinib—Musculoskeletal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.00161	0.00843	CcSEcCtD
Erlotinib—Melaena—Chenodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00814	CcSEcCtD
Erlotinib—Melaena—Ursodeoxycholic acid—primary biliary cirrhosis	0.00155	0.00814	CcSEcCtD
Erlotinib—TNK1—liver—primary biliary cirrhosis	0.00132	0.0442	CbGeAlD
Erlotinib—Gastrointestinal haemorrhage—Colchicine—primary biliary cirrhosis	0.00128	0.00673	CcSEcCtD
Erlotinib—Haemolytic anaemia—Ursodeoxycholic acid—primary biliary cirrhosis	0.00128	0.0067	CcSEcCtD
Erlotinib—Haemolytic anaemia—Chenodeoxycholic acid—primary biliary cirrhosis	0.00128	0.0067	CcSEcCtD
Erlotinib—Vandetanib—ABCG2—primary biliary cirrhosis	0.00126	0.357	CrCbGaD
Erlotinib—Renal impairment—Chenodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00635	CcSEcCtD
Erlotinib—Renal impairment—Ursodeoxycholic acid—primary biliary cirrhosis	0.00121	0.00635	CcSEcCtD
Erlotinib—Gefitinib—ABCG2—primary biliary cirrhosis	0.0012	0.339	CrCbGaD
Erlotinib—Dehydration—Colchicine—primary biliary cirrhosis	0.00119	0.00626	CcSEcCtD
Erlotinib—Cerebrovascular accident—Chenodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00617	CcSEcCtD
Erlotinib—Cerebrovascular accident—Ursodeoxycholic acid—primary biliary cirrhosis	0.00118	0.00617	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00605	CcSEcCtD
Erlotinib—Gastrointestinal haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.00115	0.00605	CcSEcCtD
Erlotinib—FLT3—liver—primary biliary cirrhosis	0.00113	0.038	CbGeAlD
Erlotinib—Alanine aminotransferase increased—Colchicine—primary biliary cirrhosis	0.00113	0.00594	CcSEcCtD
Erlotinib—ABL2—liver—primary biliary cirrhosis	0.00108	0.0363	CbGeAlD
Erlotinib—Dehydration—Chenodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00562	CcSEcCtD
Erlotinib—Dehydration—Ursodeoxycholic acid—primary biliary cirrhosis	0.00107	0.00562	CcSEcCtD
Erlotinib—EGFR—liver—primary biliary cirrhosis	0.00106	0.0354	CbGeAlD
Erlotinib—Neutropenia—Colchicine—primary biliary cirrhosis	0.00104	0.00544	CcSEcCtD
Erlotinib—PIP4K2C—liver—primary biliary cirrhosis	0.00103	0.0343	CbGeAlD
Erlotinib—Gastritis—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00535	CcSEcCtD
Erlotinib—Gastritis—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00535	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00533	CcSEcCtD
Erlotinib—Alanine aminotransferase increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.00102	0.00533	CcSEcCtD
Erlotinib—Dysphagia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000998	0.00523	CcSEcCtD
Erlotinib—Dysphagia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000998	0.00523	CcSEcCtD
Erlotinib—ULK3—liver—primary biliary cirrhosis	0.000979	0.0328	CbGeAlD
Erlotinib—Pancreatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000978	0.00512	CcSEcCtD
Erlotinib—Pancreatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000978	0.00512	CcSEcCtD
Erlotinib—Neuropathy peripheral—Colchicine—primary biliary cirrhosis	0.000971	0.00508	CcSEcCtD
Erlotinib—Stomatitis—Colchicine—primary biliary cirrhosis	0.000965	0.00505	CcSEcCtD
Erlotinib—MKNK1—liver—primary biliary cirrhosis	0.000921	0.0309	CbGeAlD
Erlotinib—Weight decreased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000903	0.00473	CcSEcCtD
Erlotinib—Weight decreased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000903	0.00473	CcSEcCtD
Erlotinib—Pneumonia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00469	CcSEcCtD
Erlotinib—Pneumonia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000895	0.00469	CcSEcCtD
Erlotinib—Infestation NOS—Chenodeoxycholic acid—primary biliary cirrhosis	0.00089	0.00466	CcSEcCtD
Erlotinib—Infestation—Chenodeoxycholic acid—primary biliary cirrhosis	0.00089	0.00466	CcSEcCtD
Erlotinib—Infestation NOS—Ursodeoxycholic acid—primary biliary cirrhosis	0.00089	0.00466	CcSEcCtD
Erlotinib—Infestation—Ursodeoxycholic acid—primary biliary cirrhosis	0.00089	0.00466	CcSEcCtD
Erlotinib—ABL1—smooth muscle tissue—primary biliary cirrhosis	0.000889	0.0298	CbGeAlD
Erlotinib—Depression—Chenodeoxycholic acid—primary biliary cirrhosis	0.000887	0.00465	CcSEcCtD
Erlotinib—Depression—Ursodeoxycholic acid—primary biliary cirrhosis	0.000887	0.00465	CcSEcCtD
Erlotinib—Acute coronary syndrome—Chenodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00459	CcSEcCtD
Erlotinib—Acute coronary syndrome—Ursodeoxycholic acid—primary biliary cirrhosis	0.000877	0.00459	CcSEcCtD
Erlotinib—Renal failure—Ursodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00458	CcSEcCtD
Erlotinib—Renal failure—Chenodeoxycholic acid—primary biliary cirrhosis	0.000875	0.00458	CcSEcCtD
Erlotinib—SLK—liver—primary biliary cirrhosis	0.000872	0.0292	CbGeAlD
Erlotinib—Myocardial infarction—Ursodeoxycholic acid—primary biliary cirrhosis	0.000872	0.00457	CcSEcCtD
Erlotinib—Myocardial infarction—Chenodeoxycholic acid—primary biliary cirrhosis	0.000872	0.00457	CcSEcCtD
Erlotinib—Conjunctivitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00453	CcSEcCtD
Erlotinib—Conjunctivitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000865	0.00453	CcSEcCtD
Erlotinib—Hepatobiliary disease—Ursodeoxycholic acid—primary biliary cirrhosis	0.000841	0.00441	CcSEcCtD
Erlotinib—Hepatobiliary disease—Chenodeoxycholic acid—primary biliary cirrhosis	0.000841	0.00441	CcSEcCtD
Erlotinib—Epistaxis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000839	0.00439	CcSEcCtD
Erlotinib—Epistaxis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000839	0.00439	CcSEcCtD
Erlotinib—Eye disorder—Colchicine—primary biliary cirrhosis	0.000831	0.00435	CcSEcCtD
Erlotinib—Haemoglobin—Ursodeoxycholic acid—primary biliary cirrhosis	0.000803	0.0042	CcSEcCtD
Erlotinib—Haemoglobin—Chenodeoxycholic acid—primary biliary cirrhosis	0.000803	0.0042	CcSEcCtD
Erlotinib—Mediastinal disorder—Colchicine—primary biliary cirrhosis	0.000801	0.0042	CcSEcCtD
Erlotinib—Haemorrhage—Ursodeoxycholic acid—primary biliary cirrhosis	0.000799	0.00418	CcSEcCtD
Erlotinib—Haemorrhage—Chenodeoxycholic acid—primary biliary cirrhosis	0.000799	0.00418	CcSEcCtD
Erlotinib—Urinary tract disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00413	CcSEcCtD
Erlotinib—Urinary tract disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000789	0.00413	CcSEcCtD
Erlotinib—Alopecia—Colchicine—primary biliary cirrhosis	0.000785	0.00411	CcSEcCtD
Erlotinib—Connective tissue disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000785	0.00411	CcSEcCtD
Erlotinib—Connective tissue disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000785	0.00411	CcSEcCtD
Erlotinib—Urethral disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000783	0.0041	CcSEcCtD
Erlotinib—Urethral disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000783	0.0041	CcSEcCtD
Erlotinib—Malnutrition—Colchicine—primary biliary cirrhosis	0.000774	0.00405	CcSEcCtD
Erlotinib—STK10—liver—primary biliary cirrhosis	0.000759	0.0254	CbGeAlD
Erlotinib—CYP1B1—smooth muscle tissue—primary biliary cirrhosis	0.000752	0.0252	CbGeAlD
Erlotinib—Eye disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000746	0.00391	CcSEcCtD
Erlotinib—Eye disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000746	0.00391	CcSEcCtD
Erlotinib—Mediastinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00072	0.00377	CcSEcCtD
Erlotinib—Mediastinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00072	0.00377	CcSEcCtD
Erlotinib—Chills—Ursodeoxycholic acid—primary biliary cirrhosis	0.000717	0.00375	CcSEcCtD
Erlotinib—Chills—Chenodeoxycholic acid—primary biliary cirrhosis	0.000717	0.00375	CcSEcCtD
Erlotinib—UGT1A1—liver—primary biliary cirrhosis	0.000716	0.024	CbGeAlD
Erlotinib—Arrhythmia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00374	CcSEcCtD
Erlotinib—Arrhythmia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000713	0.00374	CcSEcCtD
Erlotinib—Alopecia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000706	0.0037	CcSEcCtD
Erlotinib—Alopecia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000706	0.0037	CcSEcCtD
Erlotinib—Malnutrition—Chenodeoxycholic acid—primary biliary cirrhosis	0.000695	0.00364	CcSEcCtD
Erlotinib—Malnutrition—Ursodeoxycholic acid—primary biliary cirrhosis	0.000695	0.00364	CcSEcCtD
Erlotinib—Flatulence—Ursodeoxycholic acid—primary biliary cirrhosis	0.000685	0.00359	CcSEcCtD
Erlotinib—Flatulence—Chenodeoxycholic acid—primary biliary cirrhosis	0.000685	0.00359	CcSEcCtD
Erlotinib—MAP2K5—liver—primary biliary cirrhosis	0.000678	0.0227	CbGeAlD
Erlotinib—Back pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000673	0.00352	CcSEcCtD
Erlotinib—Back pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000673	0.00352	CcSEcCtD
Erlotinib—Myalgia—Colchicine—primary biliary cirrhosis	0.000659	0.00345	CcSEcCtD
Erlotinib—Arthralgia—Colchicine—primary biliary cirrhosis	0.000659	0.00345	CcSEcCtD
Erlotinib—Syncope—Chenodeoxycholic acid—primary biliary cirrhosis	0.000623	0.00327	CcSEcCtD
Erlotinib—Syncope—Ursodeoxycholic acid—primary biliary cirrhosis	0.000623	0.00327	CcSEcCtD
Erlotinib—Shock—Colchicine—primary biliary cirrhosis	0.000621	0.00325	CcSEcCtD
Erlotinib—Nervous system disorder—Colchicine—primary biliary cirrhosis	0.000619	0.00324	CcSEcCtD
Erlotinib—Thrombocytopenia—Colchicine—primary biliary cirrhosis	0.000618	0.00324	CcSEcCtD
Erlotinib—Skin disorder—Colchicine—primary biliary cirrhosis	0.000613	0.00321	CcSEcCtD
Erlotinib—Loss of consciousness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000611	0.0032	CcSEcCtD
Erlotinib—Loss of consciousness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000611	0.0032	CcSEcCtD
Erlotinib—Cough—Ursodeoxycholic acid—primary biliary cirrhosis	0.000607	0.00318	CcSEcCtD
Erlotinib—Cough—Chenodeoxycholic acid—primary biliary cirrhosis	0.000607	0.00318	CcSEcCtD
Erlotinib—Arthralgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Chest pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Myalgia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Myalgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Chest pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Arthralgia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000592	0.0031	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000588	0.00308	CcSEcCtD
Erlotinib—Unspecified disorder of skin and subcutaneous tissue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000588	0.00308	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Colchicine—primary biliary cirrhosis	0.000575	0.00301	CcSEcCtD
Erlotinib—Oedema—Ursodeoxycholic acid—primary biliary cirrhosis	0.000567	0.00297	CcSEcCtD
Erlotinib—Oedema—Chenodeoxycholic acid—primary biliary cirrhosis	0.000567	0.00297	CcSEcCtD
Erlotinib—Infection—Ursodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00295	CcSEcCtD
Erlotinib—Infection—Chenodeoxycholic acid—primary biliary cirrhosis	0.000564	0.00295	CcSEcCtD
Erlotinib—Shock—Ursodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00292	CcSEcCtD
Erlotinib—Shock—Chenodeoxycholic acid—primary biliary cirrhosis	0.000558	0.00292	CcSEcCtD
Erlotinib—Nervous system disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000556	0.00291	CcSEcCtD
Erlotinib—Nervous system disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000556	0.00291	CcSEcCtD
Erlotinib—Thrombocytopenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000556	0.00291	CcSEcCtD
Erlotinib—Thrombocytopenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000556	0.00291	CcSEcCtD
Erlotinib—CYP1A1—epithelium—primary biliary cirrhosis	0.000552	0.0185	CbGeAlD
Erlotinib—Vandetanib—ALB—primary biliary cirrhosis	0.000551	0.156	CrCbGaD
Erlotinib—Skin disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00289	CcSEcCtD
Erlotinib—Skin disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.000551	0.00289	CcSEcCtD
Erlotinib—ORM1—liver—primary biliary cirrhosis	0.00055	0.0184	CbGeAlD
Erlotinib—Decreased appetite—Colchicine—primary biliary cirrhosis	0.000549	0.00288	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Colchicine—primary biliary cirrhosis	0.000545	0.00286	CcSEcCtD
Erlotinib—Fatigue—Colchicine—primary biliary cirrhosis	0.000544	0.00285	CcSEcCtD
Erlotinib—Anorexia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000541	0.00283	CcSEcCtD
Erlotinib—Anorexia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000541	0.00283	CcSEcCtD
Erlotinib—SLCO2B1—liver—primary biliary cirrhosis	0.000527	0.0177	CbGeAlD
Erlotinib—Gefitinib—ALB—primary biliary cirrhosis	0.000524	0.148	CrCbGaD
Erlotinib—ABL1—liver—primary biliary cirrhosis	0.000523	0.0175	CbGeAlD
Erlotinib—Musculoskeletal discomfort—Ursodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00271	CcSEcCtD
Erlotinib—Musculoskeletal discomfort—Chenodeoxycholic acid—primary biliary cirrhosis	0.000517	0.00271	CcSEcCtD
Erlotinib—Gastrointestinal pain—Colchicine—primary biliary cirrhosis	0.000516	0.0027	CcSEcCtD
Erlotinib—Insomnia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000513	0.00269	CcSEcCtD
Erlotinib—Insomnia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000513	0.00269	CcSEcCtD
Erlotinib—Dyspnoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000506	0.00265	CcSEcCtD
Erlotinib—Dyspnoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000506	0.00265	CcSEcCtD
Erlotinib—Dyspepsia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000499	0.00262	CcSEcCtD
Erlotinib—Dyspepsia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000499	0.00262	CcSEcCtD
Erlotinib—Abdominal pain—Colchicine—primary biliary cirrhosis	0.000499	0.00261	CcSEcCtD
Erlotinib—Decreased appetite—Chenodeoxycholic acid—primary biliary cirrhosis	0.000493	0.00258	CcSEcCtD
Erlotinib—Decreased appetite—Ursodeoxycholic acid—primary biliary cirrhosis	0.000493	0.00258	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Ursodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00257	CcSEcCtD
Erlotinib—Gastrointestinal disorder—Chenodeoxycholic acid—primary biliary cirrhosis	0.00049	0.00257	CcSEcCtD
Erlotinib—Fatigue—Chenodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00256	CcSEcCtD
Erlotinib—Fatigue—Ursodeoxycholic acid—primary biliary cirrhosis	0.000489	0.00256	CcSEcCtD
Erlotinib—Constipation—Chenodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00254	CcSEcCtD
Erlotinib—Pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00254	CcSEcCtD
Erlotinib—Pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00254	CcSEcCtD
Erlotinib—Constipation—Ursodeoxycholic acid—primary biliary cirrhosis	0.000485	0.00254	CcSEcCtD
Erlotinib—ALB—liver—primary biliary cirrhosis	0.000482	0.0162	CbGeAlD
Erlotinib—Gastrointestinal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000464	0.00243	CcSEcCtD
Erlotinib—Gastrointestinal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000464	0.00243	CcSEcCtD
Erlotinib—Asthenia—Colchicine—primary biliary cirrhosis	0.000453	0.00237	CcSEcCtD
Erlotinib—Body temperature increased—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00235	CcSEcCtD
Erlotinib—Abdominal pain—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00235	CcSEcCtD
Erlotinib—Body temperature increased—Ursodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00235	CcSEcCtD
Erlotinib—Abdominal pain—Chenodeoxycholic acid—primary biliary cirrhosis	0.000449	0.00235	CcSEcCtD
Erlotinib—CYP1B1—liver—primary biliary cirrhosis	0.000443	0.0148	CbGeAlD
Erlotinib—Diarrhoea—Colchicine—primary biliary cirrhosis	0.000432	0.00226	CcSEcCtD
Erlotinib—Asthenia—Ursodeoxycholic acid—primary biliary cirrhosis	0.000407	0.00213	CcSEcCtD
Erlotinib—Asthenia—Chenodeoxycholic acid—primary biliary cirrhosis	0.000407	0.00213	CcSEcCtD
Erlotinib—Vomiting—Colchicine—primary biliary cirrhosis	0.000402	0.0021	CcSEcCtD
Erlotinib—Pruritus—Ursodeoxycholic acid—primary biliary cirrhosis	0.000401	0.0021	CcSEcCtD
Erlotinib—Pruritus—Chenodeoxycholic acid—primary biliary cirrhosis	0.000401	0.0021	CcSEcCtD
Erlotinib—Rash—Colchicine—primary biliary cirrhosis	0.000398	0.00209	CcSEcCtD
Erlotinib—Dermatitis—Colchicine—primary biliary cirrhosis	0.000398	0.00208	CcSEcCtD
Erlotinib—Headache—Colchicine—primary biliary cirrhosis	0.000396	0.00207	CcSEcCtD
Erlotinib—Diarrhoea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00203	CcSEcCtD
Erlotinib—Diarrhoea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000388	0.00203	CcSEcCtD
Erlotinib—Dizziness—Ursodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00197	CcSEcCtD
Erlotinib—Dizziness—Chenodeoxycholic acid—primary biliary cirrhosis	0.000375	0.00197	CcSEcCtD
Erlotinib—Nausea—Colchicine—primary biliary cirrhosis	0.000375	0.00196	CcSEcCtD
Erlotinib—Vomiting—Chenodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00189	CcSEcCtD
Erlotinib—Vomiting—Ursodeoxycholic acid—primary biliary cirrhosis	0.000361	0.00189	CcSEcCtD
Erlotinib—Rash—Chenodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00187	CcSEcCtD
Erlotinib—Rash—Ursodeoxycholic acid—primary biliary cirrhosis	0.000358	0.00187	CcSEcCtD
Erlotinib—Dermatitis—Chenodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00187	CcSEcCtD
Erlotinib—Dermatitis—Ursodeoxycholic acid—primary biliary cirrhosis	0.000357	0.00187	CcSEcCtD
Erlotinib—Headache—Ursodeoxycholic acid—primary biliary cirrhosis	0.000355	0.00186	CcSEcCtD
Erlotinib—Headache—Chenodeoxycholic acid—primary biliary cirrhosis	0.000355	0.00186	CcSEcCtD
Erlotinib—CYP2C8—liver—primary biliary cirrhosis	0.000339	0.0114	CbGeAlD
Erlotinib—Nausea—Ursodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00177	CcSEcCtD
Erlotinib—Nausea—Chenodeoxycholic acid—primary biliary cirrhosis	0.000337	0.00177	CcSEcCtD
Erlotinib—ABCG2—liver—primary biliary cirrhosis	0.00033	0.011	CbGeAlD
Erlotinib—CYP1A2—liver—primary biliary cirrhosis	0.000317	0.0106	CbGeAlD
Erlotinib—CYP1A1—liver—primary biliary cirrhosis	0.000313	0.0105	CbGeAlD
Erlotinib—CYP3A5—liver—primary biliary cirrhosis	0.000306	0.0102	CbGeAlD
Erlotinib—ABCB1—epithelium—primary biliary cirrhosis	0.000287	0.0096	CbGeAlD
Erlotinib—CYP3A4—liver—primary biliary cirrhosis	0.00023	0.00769	CbGeAlD
Erlotinib—CYP2D6—liver—primary biliary cirrhosis	0.000226	0.00757	CbGeAlD
Erlotinib—ABCB1—liver—primary biliary cirrhosis	0.000163	0.00544	CbGeAlD
Erlotinib—JAK3—Immune System—CD80—primary biliary cirrhosis	2.61e-05	0.0002	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.59e-05	0.000198	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—AQP4—primary biliary cirrhosis	2.59e-05	0.000198	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CDH5—primary biliary cirrhosis	2.54e-05	0.000194	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—HIF1A—primary biliary cirrhosis	2.53e-05	0.000194	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD40LG—primary biliary cirrhosis	2.53e-05	0.000193	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—AGT—primary biliary cirrhosis	2.52e-05	0.000193	CbGpPWpGaD
Erlotinib—EGFR—Disease—NUP210—primary biliary cirrhosis	2.51e-05	0.000192	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PDHX—primary biliary cirrhosis	2.49e-05	0.000191	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ABCC2—primary biliary cirrhosis	2.48e-05	0.00019	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCR5—primary biliary cirrhosis	2.44e-05	0.000187	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—OGDH—primary biliary cirrhosis	2.42e-05	0.000185	CbGpPWpGaD
Erlotinib—ABL1—Axon guidance—MMP9—primary biliary cirrhosis	2.42e-05	0.000185	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP3—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Erlotinib—JAK3—Signaling by GPCR—TYK2—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Erlotinib—ALB—Metabolism—OGDH—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Erlotinib—ALB—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.41e-05	0.000184	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.38e-05	0.000182	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PDHX—primary biliary cirrhosis	2.35e-05	0.00018	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCB4—primary biliary cirrhosis	2.34e-05	0.000179	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—DLAT—primary biliary cirrhosis	2.34e-05	0.000179	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—LBR—primary biliary cirrhosis	2.33e-05	0.000178	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—NUP210—primary biliary cirrhosis	2.31e-05	0.000177	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CTLA4—primary biliary cirrhosis	2.31e-05	0.000177	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP2—primary biliary cirrhosis	2.29e-05	0.000176	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	2.29e-05	0.000176	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—CD80—primary biliary cirrhosis	2.29e-05	0.000175	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CCL5—primary biliary cirrhosis	2.27e-05	0.000174	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—NUP210—primary biliary cirrhosis	2.27e-05	0.000174	CbGpPWpGaD
Erlotinib—EGFR—Signaling by NGF—NFKB1—primary biliary cirrhosis	2.26e-05	0.000173	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—CD80—primary biliary cirrhosis	2.23e-05	0.000171	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL9—primary biliary cirrhosis	2.22e-05	0.00017	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—DLAT—primary biliary cirrhosis	2.21e-05	0.000169	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCB4—primary biliary cirrhosis	2.21e-05	0.000169	CbGpPWpGaD
Erlotinib—ABL1—Hemostasis—ALB—primary biliary cirrhosis	2.2e-05	0.000169	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	2.2e-05	0.000169	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD79A—primary biliary cirrhosis	2.2e-05	0.000168	CbGpPWpGaD
Erlotinib—JAK3—Immune System—TYK2—primary biliary cirrhosis	2.2e-05	0.000168	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—TYK2—primary biliary cirrhosis	2.19e-05	0.000168	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.18e-05	0.000167	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	2.17e-05	0.000166	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TAB1—primary biliary cirrhosis	2.16e-05	0.000165	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—NUP210—primary biliary cirrhosis	2.16e-05	0.000165	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PDHX—primary biliary cirrhosis	2.16e-05	0.000165	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CXCL10—primary biliary cirrhosis	2.15e-05	0.000165	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ABCG2—primary biliary cirrhosis	2.15e-05	0.000165	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PDHX—primary biliary cirrhosis	2.14e-05	0.000164	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—OGDH—primary biliary cirrhosis	2.11e-05	0.000161	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ABCG2—primary biliary cirrhosis	2.11e-05	0.000161	CbGpPWpGaD
Erlotinib—EGFR—Axon guidance—MMP9—primary biliary cirrhosis	2.06e-05	0.000158	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—ELMO1—primary biliary cirrhosis	2.05e-05	0.000157	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	2.04e-05	0.000156	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCB4—primary biliary cirrhosis	2.03e-05	0.000155	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—DLAT—primary biliary cirrhosis	2.03e-05	0.000155	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCB4—primary biliary cirrhosis	2.02e-05	0.000154	CbGpPWpGaD
Erlotinib—ALB—Metabolism—DLAT—primary biliary cirrhosis	2.02e-05	0.000154	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ABCG2—primary biliary cirrhosis	2.01e-05	0.000154	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—OGDH—primary biliary cirrhosis	1.99e-05	0.000152	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT2—primary biliary cirrhosis	1.99e-05	0.000152	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CTLA4—primary biliary cirrhosis	1.97e-05	0.000151	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—NUP210—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP3—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP2—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—CD80—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CXCL10—primary biliary cirrhosis	1.96e-05	0.00015	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—TYK2—primary biliary cirrhosis	1.93e-05	0.000148	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.91e-05	0.000146	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—AGT—primary biliary cirrhosis	1.9e-05	0.000146	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—TYK2—primary biliary cirrhosis	1.89e-05	0.000144	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD79A—primary biliary cirrhosis	1.88e-05	0.000144	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—CD80—primary biliary cirrhosis	1.88e-05	0.000144	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PDHX—primary biliary cirrhosis	1.88e-05	0.000144	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—TYK2—primary biliary cirrhosis	1.87e-05	0.000143	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.87e-05	0.000143	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.86e-05	0.000142	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CCL5—primary biliary cirrhosis	1.85e-05	0.000142	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—CTGF—primary biliary cirrhosis	1.85e-05	0.000141	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TAB1—primary biliary cirrhosis	1.85e-05	0.000141	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT2—primary biliary cirrhosis	1.83e-05	0.00014	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.81e-05	0.000139	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—LBR—primary biliary cirrhosis	1.8e-05	0.000138	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	1.8e-05	0.000138	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD40LG—primary biliary cirrhosis	1.79e-05	0.000137	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—MMP3—primary biliary cirrhosis	1.78e-05	0.000137	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PDHX—primary biliary cirrhosis	1.77e-05	0.000136	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—DLAT—primary biliary cirrhosis	1.77e-05	0.000135	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCB4—primary biliary cirrhosis	1.77e-05	0.000135	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.76e-05	0.000135	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—MMP9—primary biliary cirrhosis	1.72e-05	0.000132	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—CTGF—primary biliary cirrhosis	1.72e-05	0.000132	CbGpPWpGaD
Erlotinib—JAK3—Immune System—NFKB1—primary biliary cirrhosis	1.71e-05	0.000131	CbGpPWpGaD
Erlotinib—EGFR—Disease—GOT1—primary biliary cirrhosis	1.71e-05	0.000131	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT2—primary biliary cirrhosis	1.71e-05	0.000131	CbGpPWpGaD
Erlotinib—ABL1—Developmental Biology—NFKB1—primary biliary cirrhosis	1.71e-05	0.000131	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—CD80—primary biliary cirrhosis	1.68e-05	0.000129	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—CCL5—primary biliary cirrhosis	1.68e-05	0.000129	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—OGDH—primary biliary cirrhosis	1.68e-05	0.000129	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—DLAT—primary biliary cirrhosis	1.66e-05	0.000128	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCB4—primary biliary cirrhosis	1.66e-05	0.000128	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.66e-05	0.000127	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.65e-05	0.000127	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—TYK2—primary biliary cirrhosis	1.65e-05	0.000127	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GGT1—primary biliary cirrhosis	1.58e-05	0.000121	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—GOT1—primary biliary cirrhosis	1.58e-05	0.000121	CbGpPWpGaD
Erlotinib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—primary biliary cirrhosis	1.57e-05	0.000121	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—CTGF—primary biliary cirrhosis	1.57e-05	0.00012	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—HIF1A—primary biliary cirrhosis	1.56e-05	0.000119	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT2—primary biliary cirrhosis	1.55e-05	0.000119	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—AGT—primary biliary cirrhosis	1.55e-05	0.000119	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD40LG—primary biliary cirrhosis	1.53e-05	0.000117	CbGpPWpGaD
Erlotinib—ABCG2—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	1.52e-05	0.000117	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—primary biliary cirrhosis	1.52e-05	0.000116	CbGpPWpGaD
Erlotinib—ABL1—Innate Immune System—NFKB1—primary biliary cirrhosis	1.51e-05	0.000115	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PDHX—primary biliary cirrhosis	1.5e-05	0.000115	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—MMP9—primary biliary cirrhosis	1.49e-05	0.000114	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—MMP9—primary biliary cirrhosis	1.47e-05	0.000113	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GOT1—primary biliary cirrhosis	1.47e-05	0.000113	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—GGT1—primary biliary cirrhosis	1.47e-05	0.000113	CbGpPWpGaD
Erlotinib—MKNK1—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.47e-05	0.000113	CbGpPWpGaD
Erlotinib—EGFR—Developmental Biology—NFKB1—primary biliary cirrhosis	1.46e-05	0.000112	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—TYK2—primary biliary cirrhosis	1.42e-05	0.000109	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCB4—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—DLAT—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—AGT—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—NUP210—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.41e-05	0.000108	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—CD80—primary biliary cirrhosis	1.37e-05	0.000105	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GGT1—primary biliary cirrhosis	1.34e-05	0.000103	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—GOT1—primary biliary cirrhosis	1.34e-05	0.000103	CbGpPWpGaD
Erlotinib—ABL1—Immune System—CD80—primary biliary cirrhosis	1.33e-05	0.000102	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—NUP210—primary biliary cirrhosis	1.33e-05	0.000102	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—PPARGC1A—primary biliary cirrhosis	1.31e-05	0.0001	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ABCG2—primary biliary cirrhosis	1.31e-05	0.0001	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—OGDH—primary biliary cirrhosis	1.3e-05	9.95e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—primary biliary cirrhosis	1.3e-05	9.95e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.29e-05	9.91e-05	CbGpPWpGaD
Erlotinib—ALB—Hemostasis—NOS2—primary biliary cirrhosis	1.29e-05	9.88e-05	CbGpPWpGaD
Erlotinib—EGFR—Innate Immune System—NFKB1—primary biliary cirrhosis	1.29e-05	9.86e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	1.29e-05	9.86e-05	CbGpPWpGaD
Erlotinib—EGFR—Adaptive Immune System—NFKB1—primary biliary cirrhosis	1.24e-05	9.47e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ABCG2—primary biliary cirrhosis	1.24e-05	9.46e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—NUP210—primary biliary cirrhosis	1.22e-05	9.33e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—NUP210—primary biliary cirrhosis	1.21e-05	9.28e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—PPARGC1A—primary biliary cirrhosis	1.19e-05	9.13e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—HIF1A—primary biliary cirrhosis	1.19e-05	9.13e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—TYK2—primary biliary cirrhosis	1.16e-05	8.88e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PDHX—primary biliary cirrhosis	1.16e-05	8.87e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—PPARGC1A—primary biliary cirrhosis	1.16e-05	8.85e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CXCL10—primary biliary cirrhosis	1.16e-05	8.85e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—CD80—primary biliary cirrhosis	1.14e-05	8.73e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ABCG2—primary biliary cirrhosis	1.13e-05	8.68e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—ABCG2—primary biliary cirrhosis	1.13e-05	8.63e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—TYK2—primary biliary cirrhosis	1.13e-05	8.62e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—CTGF—primary biliary cirrhosis	1.12e-05	8.6e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—MMP9—primary biliary cirrhosis	1.12e-05	8.58e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT2—primary biliary cirrhosis	1.11e-05	8.52e-05	CbGpPWpGaD
Erlotinib—JAK3—Signaling Pathways—NFKB1—primary biliary cirrhosis	1.11e-05	8.49e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—AGT—primary biliary cirrhosis	1.09e-05	8.38e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCB4—primary biliary cirrhosis	1.09e-05	8.34e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—DLAT—primary biliary cirrhosis	1.09e-05	8.34e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—NOS2—primary biliary cirrhosis	1.08e-05	8.31e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	1.08e-05	8.3e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—NUP210—primary biliary cirrhosis	1.06e-05	8.13e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—CTGF—primary biliary cirrhosis	1.06e-05	8.12e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP3—primary biliary cirrhosis	1.05e-05	8.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling by GPCR—TYK2—primary biliary cirrhosis	1.05e-05	8.07e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—CD80—primary biliary cirrhosis	1.05e-05	8.06e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT2—primary biliary cirrhosis	1.05e-05	8.05e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—AGT—primary biliary cirrhosis	1.02e-05	7.82e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—NUP210—primary biliary cirrhosis	1e-05	7.66e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CCL5—primary biliary cirrhosis	9.95e-06	7.62e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	9.93e-06	7.61e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ABCG2—primary biliary cirrhosis	9.87e-06	7.56e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—CTGF—primary biliary cirrhosis	9.72e-06	7.44e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—CTGF—primary biliary cirrhosis	9.67e-06	7.4e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—RPS6KB1—primary biliary cirrhosis	9.64e-06	7.38e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT2—primary biliary cirrhosis	9.63e-06	7.38e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—TYK2—primary biliary cirrhosis	9.62e-06	7.37e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GGT1—primary biliary cirrhosis	9.6e-06	7.35e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—GOT1—primary biliary cirrhosis	9.6e-06	7.35e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT2—primary biliary cirrhosis	9.58e-06	7.34e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ABCG2—primary biliary cirrhosis	9.3e-06	7.12e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—AGT—primary biliary cirrhosis	9.29e-06	7.11e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—MMP9—primary biliary cirrhosis	9.13e-06	6.99e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GGT1—primary biliary cirrhosis	9.07e-06	6.95e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—GOT1—primary biliary cirrhosis	9.07e-06	6.95e-05	CbGpPWpGaD
Erlotinib—MAP2K5—Signaling Pathways—NFKB1—primary biliary cirrhosis	9.03e-06	6.92e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—AGT—primary biliary cirrhosis	9e-06	6.89e-05	CbGpPWpGaD
Erlotinib—EGFR—Disease—TYK2—primary biliary cirrhosis	8.89e-06	6.8e-05	CbGpPWpGaD
Erlotinib—ABL1—Immune System—NFKB1—primary biliary cirrhosis	8.77e-06	6.72e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—PPARGC1A—primary biliary cirrhosis	8.55e-06	6.54e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—NUP210—primary biliary cirrhosis	8.48e-06	6.49e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—CTGF—primary biliary cirrhosis	8.47e-06	6.49e-05	CbGpPWpGaD
Erlotinib—UGT1A1—Metabolism—ALB—primary biliary cirrhosis	8.4e-06	6.43e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT2—primary biliary cirrhosis	8.39e-06	6.43e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—HIF1A—primary biliary cirrhosis	8.35e-06	6.4e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—AGT—primary biliary cirrhosis	8.32e-06	6.37e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GOT1—primary biliary cirrhosis	8.32e-06	6.37e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—GGT1—primary biliary cirrhosis	8.32e-06	6.37e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GOT1—primary biliary cirrhosis	8.27e-06	6.33e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—GGT1—primary biliary cirrhosis	8.27e-06	6.33e-05	CbGpPWpGaD
Erlotinib—ABCB1—Transmembrane transport of small molecules—ALB—primary biliary cirrhosis	8.23e-06	6.3e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—PPARGC1A—primary biliary cirrhosis	8.07e-06	6.18e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—CTGF—primary biliary cirrhosis	7.98e-06	6.11e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT2—primary biliary cirrhosis	7.91e-06	6.06e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ABCG2—primary biliary cirrhosis	7.88e-06	6.03e-05	CbGpPWpGaD
Erlotinib—CYP1B1—Metabolism—ALB—primary biliary cirrhosis	7.84e-06	6e-05	CbGpPWpGaD
Erlotinib—EGFR—Immune System—NFKB1—primary biliary cirrhosis	7.5e-06	5.74e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—PPARGC1A—primary biliary cirrhosis	7.4e-06	5.67e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—CD80—primary biliary cirrhosis	7.37e-06	5.64e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—PPARGC1A—primary biliary cirrhosis	7.36e-06	5.64e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GGT1—primary biliary cirrhosis	7.25e-06	5.55e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—GOT1—primary biliary cirrhosis	7.25e-06	5.55e-05	CbGpPWpGaD
Erlotinib—ABCG2—Metabolism—ALB—primary biliary cirrhosis	7.13e-06	5.46e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—primary biliary cirrhosis	6.91e-06	5.29e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GOT1—primary biliary cirrhosis	6.83e-06	5.23e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—GGT1—primary biliary cirrhosis	6.83e-06	5.23e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—CTGF—primary biliary cirrhosis	6.76e-06	5.18e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT2—primary biliary cirrhosis	6.7e-06	5.13e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—AGT—primary biliary cirrhosis	6.66e-06	5.1e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—NUP210—primary biliary cirrhosis	6.54e-06	5.01e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—PPARGC1A—primary biliary cirrhosis	6.45e-06	4.94e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—AGT—primary biliary cirrhosis	6.29e-06	4.82e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—TYK2—primary biliary cirrhosis	6.22e-06	4.76e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ABCG2—primary biliary cirrhosis	6.08e-06	4.66e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—PPARGC1A—primary biliary cirrhosis	6.08e-06	4.65e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GGT1—primary biliary cirrhosis	5.78e-06	4.43e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—GOT1—primary biliary cirrhosis	5.78e-06	4.43e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—AGT—primary biliary cirrhosis	5.76e-06	4.41e-05	CbGpPWpGaD
Erlotinib—ALB—Metabolism—AGT—primary biliary cirrhosis	5.73e-06	4.39e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—CTGF—primary biliary cirrhosis	5.22e-06	4e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT2—primary biliary cirrhosis	5.17e-06	3.96e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—PPARGC1A—primary biliary cirrhosis	5.15e-06	3.94e-05	CbGpPWpGaD
Erlotinib—CYP3A5—Metabolism—ALB—primary biliary cirrhosis	5.11e-06	3.91e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—AGT—primary biliary cirrhosis	5.02e-06	3.85e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—MMP9—primary biliary cirrhosis	4.9e-06	3.75e-05	CbGpPWpGaD
Erlotinib—EGFR—Signaling Pathways—NFKB1—primary biliary cirrhosis	4.85e-06	3.71e-05	CbGpPWpGaD
Erlotinib—CYP1A1—Metabolism—ALB—primary biliary cirrhosis	4.83e-06	3.7e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—AGT—primary biliary cirrhosis	4.73e-06	3.62e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GOT1—primary biliary cirrhosis	4.46e-06	3.42e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—GGT1—primary biliary cirrhosis	4.46e-06	3.42e-05	CbGpPWpGaD
Erlotinib—CYP2C8—Metabolism—ALB—primary biliary cirrhosis	4.42e-06	3.39e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—AGT—primary biliary cirrhosis	4.01e-06	3.07e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—PPARGC1A—primary biliary cirrhosis	3.97e-06	3.04e-05	CbGpPWpGaD
Erlotinib—ABCB1—Metabolism—ALB—primary biliary cirrhosis	3.85e-06	2.95e-05	CbGpPWpGaD
Erlotinib—CYP2D6—Metabolism—ALB—primary biliary cirrhosis	3.63e-06	2.78e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—AGT—primary biliary cirrhosis	3.09e-06	2.37e-05	CbGpPWpGaD
Erlotinib—CYP1A2—Metabolism—ALB—primary biliary cirrhosis	3.08e-06	2.36e-05	CbGpPWpGaD
Erlotinib—CYP3A4—Metabolism—ALB—primary biliary cirrhosis	2.37e-06	1.82e-05	CbGpPWpGaD
